TransMedics Group Quarterly Balance Sheet

NASDAQ: TMDXHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

77.87-1.13 (-1.43%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

TransMedics Group financial position

As of Jun 30, 2026, TransMedics Group reported total assets of $1.46 billion, up 64.4% from a year earlier against total liabilities of $946.3 million. Shareholders' equity stood at $518.1 million, or 35.4% of assets. The company held $472.7 million in cash and equivalents against $59.7 million of debt, a net cash position of $412.9 million.

The current ratio (current assets divided by current liabilities) was 6.62, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.12.

Summary generated from market data by MetaCap's automated system. Methodology

TransMedics Group balance sheet (quarterly)

TransMedics Group quarterly balance sheet
Quarter (USD)	Q2 20262026-06-30	Q1 20262026-03-31	Q4 20252025-12-31	Q3 20252025-09-30	Q2 20252025-06-30	Q1 20252025-03-31	Q4 20242024-12-31	Q3 20242024-09-30	Q2 20242024-06-30	Q1 20242024-03-31	Q4 20232023-12-31	Q3 20232023-09-30
Cash & Equivalents	472.68M	461.74M	488.37M	466.17M	400.57M	310.14M	336.65M	330.09M	362.75M	350.22M	394.81M	427.11M
Receivables	104.14M	90.73M	84.28M	80.70M	104.85M	142.03M	97.72M	90.13M	81.16M	81.94M	63.58M	60.65M
Inventory	54.14M	49.89M	48.88M	44.51M	38.87M	43.38M	46.55M	52.15M	48.67M	48.54M	44.23M	39.37M
Total Current Assets	651.12M	619.28M	637.78M	613.00M	558.13M	505.92M	497.22M	492.48M	509.26M	488.31M	510.65M	536.72M
Property, Plant & Equipment	365.30M	361.57M	327.66M	313.02M	312.25M	311.24M	285.97M	271.74M	229.03M	214.42M	173.94M	131.00M
Goodwill	11.55M	11.55M	11.55M	11.55M	11.55M	11.55M	11.55M	11.55M	11.55M	11.99M	11.99M	11.67M
Intangible Assets	0	0	1.95M	2.00M	2.05M	2.10M	2.15M	2.20M	2.25M	2.30M	2.35M	2.40M
Total Assets	1.46B	1.43B	1.07B	946.03M	890.52M	837.53M	804.08M	785.57M	758.58M	723.83M	706.05M	689.23M
Accounts Payable	12.91M	11.15M	10.35M	12.16M	9.54M	10.60M	10.29M	13.13M	13.03M	9.22M	12.72M	12.84M
Short-Term Debt	20.00M	15.00M	10.00M	5.00M	—	—	—	—	—	—	—	—
Total Current Liabilities	98.28M	91.92M	89.31M	79.72M	56.62M	55.60M	59.91M	60.05M	54.33M	50.22M	54.93M	49.10M
Long-Term Debt	39.74M	44.66M	49.59M	54.60M	59.52M	59.45M	59.37M	59.29M	59.22M	59.14M	59.06M	58.99M
Total Liabilities	946.34M	940.81M	595.27M	590.83M	572.42M	571.22M	575.47M	575.65M	568.68M	564.36M	568.85M	562.77M
Shareholders' Equity	518.05M	494.01M	473.10M	355.20M	318.10M	266.31M	228.60M	209.92M	189.89M	159.47M	137.20M	126.46M
Retained Earnings	-255.95M	-270.63M	-277.95M	-383.33M	-407.65M	-442.56M	-468.24M	-475.10M	-479.31M	-491.51M	-503.70M	-507.74M
Total Debt	59.74M	59.66M	59.59M	59.60M	59.52M	59.45M	59.37M	59.29M	59.22M	59.14M	59.06M	58.99M
Net Cash (Debt)	412.93M	402.07M	428.78M	406.57M	341.05M	250.69M	277.28M	270.80M	303.53M	291.08M	335.75M	368.12M
Shares Outstanding	34.63M	34.55M	34.27M	34.14M	34.04M	33.83M	33.62M	33.56M	33.31M	32.85M	32.67M	32.64M

This table shows 12 quarterly periods of TransMedics Group's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow TMDX's reporting calendar. What is a balance sheet?